Meetings and Seminars

III UNITO-POLITO Conference in Cancer "Nanoscience in cancer Immunotherapy" taking place on 11-13 March 2020, we want to give you the opportunity to find a challenging trans-disciplinary environment where the latest findings in tumor immunology, model systems and nanotechnology-based delivery systems will be discussed to foster progress in cancer immunotherapy.

This workshop will bring together an outstanding faculty of translational and clinical oncologists who will debate the following issues:
1) the molecular understanding of the reciprocal interaction between tumor cells and their microenvironment;
2) the identification of factors that influence the cross-talk between tumor and infiltrated cells;
3) the balance between anti-tumor immunity and immunosuppression;
4) novel therapeutic approaches.

L’evento, dedicato ai pazienti con malattie mieloproliferative croniche, avrà luogo a Firenze, dalle 10 alle 16.30 presso l’Auditorium CTO , in Largo Palagi, 1
L’iscrizione è obbligatoria.

After a highly successful inaugural meeting in 2018, the Cancer Research UK Brain Tumour Conference returns this spring (London 12–14 May 2020). Join us for a packed three-day programme designed to stimulate fresh thinking and debate in brain tumour research and accelerate impact for patients. Our abstract deadline is fast approaching – don’t miss your chance to showcase your work alongside a stellar line-up of international experts, including Luis Parada (Memorial Sloan Kettering Cancer Center), Gabriele Bergers (VIB–KU Leuven Centre for Cancer Biology) and keynote speakers, Nobel Prize winner Sir Peter J Ratcliffe (University of Oxford, The Francis Crick Institute) and Douglas Hanahan (Swiss Institute for Experimental Cancer Research).
Abstract deadline:

Friday 21 February

This EACR Conference, the second on the topic following a sold-out 2019 edition, will provide a comprehensive overview of liquid biopsies in cancer. It will cover what is already in clinical practice, what is on the horizon for liquid biopsies in cancer patient management and the latest new techniques for high sensitivity profiling of solid tumors in the blood.